Printer Friendly

Acumen Public Affairs names Thomas Bols new strategy director.

M2 PHARMA-March 9, 2018-Acumen Public Affairs names Thomas Bols new strategy director

(C)2018 M2 COMMUNICATIONS

Acumen Public Affairs, an independent consultancy, has named Thomas Bols as its new strategy director, it was reported yesterday.

In the new role, Bols will concentrate on reinforcing Acumen's healthcare practice.

Bols has expertise in assisting healthcare companies with strategic communications and public affairs projects and his career history has seen him in variety of consulting and corporate positions including Amgen, Merck and Biogen. He has worked in the areas of market access, government affairs, public affairs, health policy and corporate communications to name a few and he has also advised companies engaging with policy makers, patient representatives, media, regulators and payers.

((Comments on this story may be sent to info@m2.com))

COPYRIGHT 2018 Normans Media Ltd.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2018 Gale, Cengage Learning. All rights reserved.

 
Article Details
Printer friendly Cite/link Email Feedback
Publication:M2 Pharma
Date:Mar 9, 2018
Words:129
Previous Article:Novartis to use Science 37's Network Oriented Research Assistant technology.
Next Article:EUSA Pharma names new director.
Topics:

Terms of use | Privacy policy | Copyright © 2018 Farlex, Inc. | Feedback | For webmasters